Linker Pharmaceuticals ApS
CVR 44308622 · Private limited company (ApS) · Active · Medium risk
Linker Pharmaceuticals ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 2 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 57k and a net result of DKK -268k. CEO: Kasper Pasternak Jørgensen.
Bankruptcy risk for Linker Pharmaceuticals ApS
1.0 × the average (1.41%) · higher risk than 75% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44308622
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- Amaliegade 13, 3.
1256 København K - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 44k
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 53.3% |
| Current ratio | 214% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 52 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -341k | DKK -48k |
| Net profit | DKK -268k | DKK -39k |
| Equity | DKK 57k | DKK 281k |
| Total assets | DKK 107k | DKK 327k |
| Cash | DKK 3,577 | – |
| Short-term debt | DKK 50k | – |
| Avg. employees | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 184 | Late | |
| 15 Sep 2023 – 31 Dec 2024 | 181 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Kasper Pasternak Jørgensen | Current | |
| Owner (100%) | Resistance Oncology ApS | Current | |
| Owner (100%) | Resistance Oncology ApS | ||
| Owner (90%) | Resistance Oncology ApS | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | Resistance Oncology ApS | Current |
The CEOs' other companies
Kasper Pasternak Jørgensen – 12 other companies
- CORTRIS ApS Active
- HAMIRO HOLDING ApS Active
- JAKOB & PARTNERS ApS Active
- NORDICMODERN ApS Active
- NORDICMODERN Holding ApS Active
- PASTERNAK JØRGENSEN HOLDING ApS Active
- PJ Properties ApS Active
- PJM Group ApS Active
- Pasternak Holding ApS Active
- Resistance Oncology ApS Active
- Sample Watch ApS Active
- TPR-GROUP ApS Active
Address history (0 moves)
| Amaliegade 13, 3., 1256 København K |
Other companies at the same address
- STRANDGAARD DANMARK ApS Bankrupt
- Timefly Memories IVS Bankrupt
- Alexander Meier Holding ApS Active
- Beyond Wild ApS Active
- CARL EJLER RASMUSSEN HOLDING A/S Fusioneret
- CD 12 ApS Fusioneret
- CD 5 ApS Fusioneret
- CERACO DEVELOPMENT A/S Fusioneret
- CERACO HOLDING A/S Fusioneret
- CERACO POLAND HOLDING A/S Fusioneret
- CERCO 9 ApS Fusioneret
- CORTRIS ApS Active
- EJENDOMSSELSKABET FREDERIKSBORGGADE ApS Opløst
- EJENDOMSSELSKABET BOAVISTA ApS Fusioneret
- FILM TRULY ApS Active
- HAMIRO HOLDING ApS Active
- HERSTED GRUPPEN ApS Opløst
- HPA Holding 2025 ApS Active
- Holding My Horses ApS Active
- INGRIDHUS ApS Fusioneret
- JAALCL HOLDING ApS Fusioneret
- JACOB STRUCKMANN HOLDING 2 ApS Fusioneret
- JACOB STRUCKMANN HOLDING ApS Fusioneret
- JAKOB & PARTNERS ApS Active
- JPJ Holding 2025 ApS Active
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about Linker Pharmaceuticals ApS
Has Linker Pharmaceuticals ApS gone bankrupt?
No, Linker Pharmaceuticals ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Linker Pharmaceuticals ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of Linker Pharmaceuticals ApS?
Kasper Pasternak Jørgensen is the CEO of Linker Pharmaceuticals ApS.
Who is the auditor of Linker Pharmaceuticals ApS?
Linker Pharmaceuticals ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Linker Pharmaceuticals ApS founded?
Linker Pharmaceuticals ApS was founded on 15 September 2023.
What is the equity of Linker Pharmaceuticals ApS?
Equity was DKK 57k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.